{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:59:28Z","timestamp":1787065168374,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":645,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1038\/mtna.2015.21","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T11:22:18Z","timestamp":1441106538000},"page":"e248","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2"],"prefix":"10.1016","volume":"4","author":[{"given":"Mattia","family":"Capulli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Maurizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Rucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Teti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mtna.2015.21_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/wdev.152","article-title":"Kidney: polycystic kidney disease","volume":"3","author":"Paul","year":"2014","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"key":"10.1038\/mtna.2015.21_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.visres.2012.09.012","article-title":"Current mutation discovery approaches in Retinitis Pigmentosa","volume":"75","author":"Anasagasti","year":"2012","journal-title":"Vision Res"},{"key":"10.1038\/mtna.2015.21_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bone.2007.08.029","article-title":"Genetics, pathogenesis and complications of osteopetrosis","volume":"42","author":"Del Fattore","year":"2008","journal-title":"Bone"},{"key":"10.1038\/mtna.2015.21_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.hrthm.2012.09.124","article-title":"RNA interference targeting E637K mutation rescues hERG channel currents and restores its kinetic properties","volume":"10","author":"Lu","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1038\/mtna.2015.21_bib5","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/jid.2012.28","article-title":"Generic and personalized RNAi-based therapeutics for a dominant-negative epidermal fragility disorder","volume":"132","author":"Leslie Pedrioli","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mtna.2015.21_bib6","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1038\/mtna.2015.21_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature07756","article-title":"Small RNAs in transcriptional gene silencing and genome defence","volume":"457","author":"Moazed","year":"2009","journal-title":"Nature"},{"key":"10.1038\/mtna.2015.21_bib8","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/biot.201100054","article-title":"Current progress of siRNA\/shRNA therapeutics in clinical trials","volume":"6","author":"Burnett","year":"2011","journal-title":"Biotechnol J"},{"key":"10.1038\/mtna.2015.21_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/B978-0-12-386509-0.00014-4","article-title":"Generation of hairpin-based RNAi vectors for biological and therapeutic application","volume":"507","author":"Boudreau","year":"2012","journal-title":"Methods Enzymol"},{"key":"10.1038\/mtna.2015.21_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm2632","article-title":"Biogenesis of small RNAs in animals","volume":"10","author":"Kim","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/mtna.2015.21_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/11534450-000000000-00000","article-title":"Strategies for in vivo delivery of siRNAs: recent progress","volume":"24","author":"Higuchi","year":"2010","journal-title":"BioDrugs"},{"key":"10.1038\/mtna.2015.21_bib12","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1021\/jo2012225","article-title":"Chemical modification of siRNA bases to probe and enhance RNA interference","volume":"76","author":"Peacock","year":"2011","journal-title":"J Org Chem"},{"key":"10.1038\/mtna.2015.21_bib13","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00018-013-1502-2","article-title":"Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology","volume":"71","author":"Gomes-da-Silva","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1038\/mtna.2015.21_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00439-013-1288-1","article-title":"Silencing human genetic diseases with oligonucleotide-based therapies","volume":"132","author":"Mart\u00ednez","year":"2013","journal-title":"Hum Genet"},{"key":"10.1038\/mtna.2015.21_bib15","first-page":"156","article-title":"Design and validation of siRNAs and shRNAs","volume":"11","author":"Tilesi","year":"2009","journal-title":"Curr Opin Mol Ther"},{"key":"10.1038\/mtna.2015.21_bib16","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2147\/OTT.S49652","article-title":"Antisense therapeutics in oncology: current status","volume":"7","author":"Farooqi","year":"2014","journal-title":"Onco Targets Ther"},{"key":"10.1038\/mtna.2015.21_bib17","doi-asserted-by":"crossref","first-page":"e00170","DOI":"10.1042\/BSR20140124","article-title":"siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo","volume":"35","author":"Hu","year":"2014","journal-title":"Biosci Rep"},{"key":"10.1038\/mtna.2015.21_bib18","doi-asserted-by":"crossref","first-page":"6878","DOI":"10.1038\/srep06878","article-title":"Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: sequential delivery of doxorubicin and Bcl-2 siRNA","volume":"4","author":"Yoon","year":"2014","journal-title":"Sci Rep"},{"key":"10.1038\/mtna.2015.21_bib19","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.addr.2011.09.002","article-title":"RNA therapeutics targeting osteoclast-mediated excessive bone resorption","volume":"64","author":"Wang","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1038\/mtna.2015.21_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm.2617","article-title":"A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat Med"},{"key":"10.1038\/mtna.2015.21_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/gt.2014.97","article-title":"Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors","volume":"22","author":"Essex","year":"2015","journal-title":"Gene Ther"},{"key":"10.1038\/mtna.2015.21_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/ph6040440","article-title":"Design of siRNA Therapeutics from the Molecular Scale","volume":"6","author":"Angart","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1038\/mtna.2015.21_bib23","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.1093\/nar\/gkp835","article-title":"Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs","volume":"37","author":"Huang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2015.21_bib24","doi-asserted-by":"crossref","first-page":"e2248","DOI":"10.1371\/journal.pone.0002248","article-title":"Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi","volume":"3","author":"Ohnishi","year":"2008","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2015.21_bib25","first-page":"365","article-title":"R\u00f6ntgenbilder einer seltenen Knock-enerkrankung","volume":"5","author":"Albers-Sch\u00f6nberg","year":"1904","journal-title":"Munch Med Wochenscher"},{"key":"10.1038\/mtna.2015.21_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-5793(95)01298-2","article-title":"ClC-6 and ClC-7 are two novel broadly expressed members of the CLC chloride channel family","volume":"377","author":"Brandt","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1038\/mtna.2015.21_bib27","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature06907","article-title":"The Cl-\/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes","volume":"453","author":"Graves","year":"2008","journal-title":"Nature"},{"key":"10.1038\/mtna.2015.21_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","article-title":"Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man","volume":"104","author":"Kornak","year":"2001","journal-title":"Cell"},{"key":"10.1038\/mtna.2015.21_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.abb.2014.08.009","article-title":"Reprint of: The Great Beauty of the osteoclast","volume":"561","author":"Cappariello","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"10.1038\/mtna.2015.21_bib30","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.1188072","article-title":"Lysosomal pathology and osteopetrosis upon loss of H+-driven lysosomal Cl- accumulation","volume":"328","author":"Weinert","year":"2010","journal-title":"Science"},{"key":"10.1038\/mtna.2015.21_bib31","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1530\/EJE-13-0136","article-title":"Genetic in endocrinology: autosomal dominant osteopetrosis revisited: lessons from recent studies","volume":"169","author":"Bollerslev","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/mtna.2015.21_bib32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jc.2006-1986","article-title":"Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation","volume":"92","author":"Waguespack","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/mtna.2015.21_bib33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jmg.2005.036673","article-title":"Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment","volume":"43","author":"Del Fattore","year":"2006","journal-title":"J Med Genet"},{"key":"10.1038\/mtna.2015.21_bib34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bone.2013.10.021","article-title":"Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models","volume":"59","author":"Alam","year":"2014","journal-title":"Bone"},{"key":"10.1038\/mtna.2015.21_bib35","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1359\/jbmr.060409","article-title":"Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties","volume":"21","author":"Chu","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1038\/mtna.2015.21_bib36","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ejpb.2010.11.007","article-title":"Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung","volume":"77","author":"G\u00fcnther","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1038\/mtna.2015.21_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2013.05.015","article-title":"Systemic delivery of sticky siRNAs targeting the cell cycle for lung tumor metastasis inhibition","volume":"170","author":"Bonnet","year":"2013","journal-title":"J Control Release"},{"key":"10.1038\/mtna.2015.21_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"10.1038\/mtna.2015.21_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S8756-3282(99)00244-6","article-title":"Type II autosomal dominant osteopetrosis (Albers-Sch\u00f6nberg disease): clinical and radiological manifestations in 42 patients","volume":"26","author":"B\u00e9nichou","year":"2000","journal-title":"Bone"},{"key":"10.1038\/mtna.2015.21_bib40","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1359\/jbmr.2003.18.10.1740","article-title":"Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis","volume":"18","author":"Frattini","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1038\/mtna.2015.21_bib41","series-title":"J Bone Miner Res","article-title":"Interferon gamma, but not calcitriol improves the osteopetrotic phenotypes in ADO2 mice","author":"Alam","year":"2015"},{"key":"10.1038\/mtna.2015.21_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd3010","article-title":"Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application","volume":"9","author":"Jackson","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1038\/mtna.2015.21_bib43","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0002-9440(10)63267-1","article-title":"Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis","volume":"165","author":"Kim","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1038\/mtna.2015.21_bib44","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1021\/mp500367k","article-title":"Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics","volume":"11","author":"Gindy","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1038\/mtna.2015.21_bib45","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1200\/JCO.2013.55.0376","article-title":"First-in-human phase I study of the liposomal RNA interference therapeutic Atu027 in patients with advanced solid tumors","volume":"32","author":"Schultheis","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1038\/mtna.2015.21_bib46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11914-011-0078-8","article-title":"Bone development: overview of bone cells and signaling","volume":"9","author":"Teti","year":"2011","journal-title":"Curr Osteoporos Rep"},{"key":"10.1038\/mtna.2015.21_bib47","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1364\/JOSAA.1.000612","article-title":"Practical cone-beam algorithm","volume":"1","author":"Feldkamp","year":"1984","journal-title":"J Opt So Am"},{"key":"10.1038\/mtna.2015.21_bib48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1145\/37402.37422","article-title":"Marching cubes: a high resolution 3d surface construction algorithm","volume":"21","author":"Lorensen","year":"1987","journal-title":"Computer Graphics"},{"key":"10.1038\/mtna.2015.21_bib49","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1109\/10.133215","article-title":"Real-time digital median frequency estimator for surface myoelectric signals","volume":"38","author":"Pratt","year":"1991","journal-title":"IEEE Trans Biomed Eng"},{"key":"10.1038\/mtna.2015.21_bib50","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1038\/mtna.2015.21_bib51","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1083\/jcb.200906014","article-title":"The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis","volume":"187","author":"Rucci","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1038\/mtna.2015.21_bib52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253116300348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253116300348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T17:13:21Z","timestamp":1599498801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253116300348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":52,"alternative-id":["S2162253116300348"],"URL":"https:\/\/doi.org\/10.1038\/mtna.2015.21","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"article-number":"e248"}}